A study to measure the absorption, metabolism and excretion of a single dose of radiolabelled TA-8995 (10mg) in healthy male subjects.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
6
Covance Clinical Research Unit Ltd
Leeds, United Kingdom
AUC of TA-8995
Time frame: 35 days
Mass balance recovery of total radioactivity from excreta for radiolabelled TA-8995
Time frame: 35 days
Measure the amount of radiolabelled TA-8995 recovered from urine and faeces.
Time frame: 35 days
Measure the levels of major metabolites of TA-8995 in plasma, urine and faeces after oral administration of radiolabelled TA-8995
Time frame: 35 days
Elimination of half-life of radiolabelled TA-8995
Time frame: 35 days
Number of adverse events
Time frame: 35 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.